Biblio

Author Title Type [ Year(Desc)]
Filters: Author is Baghaei, Kaveh  [Clear All Filters]
2023
Khosravi M, Rahimi HMohammad, Nazari A, Baghaei K, Aghdaei HAsadzadeh, Shahrokh S, Sharifdini M, Torrecilhas AClaudia, Mehryab F, Mirjalali H, et al. Characterisation of extracellular vesicles isolated from hydatid cyst fluid and evaluation of immunomodulatory effects on human monocytes. J Cell Mol Med. 2023.
Ghazvinian Z, Abdolahi S, Ahmadvand M, Emami AHossein, Muhammadnejad S, Aghdaei HAsadzadeh, Ai J, Zali MReza, Seyhoun I, Verdi J, et al. Chemo-immune cell therapy by intratumoral injection of adoptive NK cells with capecitabine in gastric cancer xenograft model. Bioimpacts. 2023;13(5):383-392.
Niknam B, Baghaei K, Hashemi SMahmoud, Hatami B, Zali MReza, Amani D. Human Wharton's jelly mesenchymal stem cells derived-exosomes enriched by miR-124 promote an anti-fibrotic response in an experimental model of liver fibrosis. Int Immunopharmacol. 2023;119:110294.
Azizsoltani A, Hatami B, Zali MReza, Mahdavi V, Baghaei K, Alizadeh E. Obeticholic acid-loaded exosomes attenuate liver fibrosis through dual targeting of the FXR signaling pathway and ECM remodeling. Biomed Pharmacother. 2023;168:115777.
Ghani S, Bandehpour M, Yarian F, Baghaei K, Kazemi B. Production of a Ribosome-Displayed Mouse scFv Antibody Against CD133, Analysis of Its Molecular Docking, and Molecular Dynamic Simulations of Their Interactions. Appl Biochem Biotechnol. 2023.
Siapoush S, Rezaei R, Alavifard H, Hatami B, Zali MReza, Vosough M, Lorzadeh S, Łos MJ, Baghaei K, Ghavami S. Therapeutic implications of targeting autophagy and TGF-β crosstalk for the treatment of liver fibrosis. Life Sci. 2023:121894.